Copper Crisis Looms As Nations Rush To Secure Supplies In Quest For Low-Carbon Future
The World’s Attention is on Copper: Uncovering the Latest Developments in the Critical Energy …
02. November 2025
Robotics Pioneers Unveil Breakthrough Partnership To Save More Lives
Remedy Robotics Inc. and Mission Thrombectomy have collaborated to expand the reach of blood clot removal technology, known as endovascular thrombectomy, to more patients worldwide. This strategic partnership aims to make the cutting-edge telerobotic system available to stroke patients in underserved regions and beyond.
The partnership marks a significant milestone for both organizations, with Remedy Robotics becoming Mission Thrombectomy’s exclusive robotics partner. As part of this agreement, Remedy will work closely with Mission Thrombectomy’s clinical network to test, develop, and guide the global rollout of its N1 System, a remotely operated endovascular robot designed to treat cardiovascular conditions such as stroke, heart attack, or vascular trauma.
Only one-third of Americans have access to endovascular thrombectomy without delay, while in low-income countries, the mean access rate is less than 1%. This disparity highlights the urgent need for a scalable and reliable solution to make safe and effective thrombectomy available to patients everywhere. The recent MT-GLASS study by Mission Thrombectomy found that 97% of patients are left untreated due to lack of access to this life-saving treatment.
Remedy Robotics developed its N1 System earlier this year, a proprietary hardware and AI-enabled software combination that enables faster, safer, and more effective treatment of cardiovascular conditions. The system has been successfully tested in Toronto, with the company completing its first fully remote procedures. Remedy Robotics has also partnered with the Australian Stroke Alliance to expand remote care, further solidifying its position as a leader in endovascular robotics.
However, with increased competition from competitors such as Microbot Medical and Stereotaxis, Remedy must continue to innovate and improve its technology to stay ahead in the market. The partnership between Remedy Robotics and Mission Thrombectomy is built on a shared vision of making the best endovascular intervention available to patients worldwide.
To achieve this goal, the two organizations will collaborate with regional committees in over 100 countries and the broader Society of Vascular and Interventional Neurology (SVIN) network. This global approach ensures that the benefits of endovascular thrombectomy are not limited by geographical location or socioeconomic status.
The partnership marks a significant shift towards remote stroke care. With its N1 System, Remedy is poised to revolutionize the way clinicians provide endovascular intervention, allowing patients to receive the best possible care from anywhere in the world. By harnessing the power of telerobotic technology, both organizations aim to improve patient outcomes, reduce healthcare costs, and make high-quality stroke treatment more accessible to underserved communities.
As the global landscape for stroke care continues to evolve, this partnership is poised to play a critical role in shaping the future of remote stroke care. The collaboration between Remedy Robotics and Mission Thrombectomy serves as a rallying cry for healthcare professionals, policymakers, and advocacy groups worldwide. It is imperative that we prioritize expanding access to endovascular thrombectomy.
By working together, we can bridge the gap in access to this life-saving treatment, ensuring that every patient, regardless of their location or socioeconomic status, has an equal chance of receiving timely and effective care. As the stakes have never been higher, it is our collective responsibility to drive innovation, improve outcomes, and make a meaningful difference in the lives of stroke patients worldwide.
The partnership represents a significant milestone in the fight against stroke-related mortality. By expanding access to blood clot removal technology, both organizations aim to make high-quality stroke treatment more accessible to underserved communities worldwide. As we move forward, it is essential that we prioritize innovation, collaboration, and equitable access to life-saving treatments.